Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-γ

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 5, 1998, Pages 631-642

  Umland, Shelby P ^a   Razac, Shad ^a   Shah, Himanshu ^a   Nahrebne, D Kyle ^a   Egan, Robert W ^a   Billah, M Motasim ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN; DACTINOMYCIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN DERIVATIVE; MESSENGER RNA; MONOCLONAL ANTIBODY; NUCLEIC ACID SYNTHESIS INHIBITOR;

ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; METABOLISM; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOSPORINE; DACTINOMYCIN; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-3; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKINS; KINETICS; NUCLEIC ACID SYNTHESIS INHIBITORS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032063367     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.5.3046     Document Type: Article

References (46)

1. Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindqvist, M. Takahashi, F. Matsuda, Y. Yaoita, K. Takatsu, and T. Honjo. 1986. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324:70-73.
2. Warren, D. J., and M. S. Moore. 1988. Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. J. Immunol. 140:94-99.
3. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Taminaga, and K. Takutsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43-56.
4. Wang, J. M., A. Rambaldi, A. Biondi, Z. G. Chen, C. J. Sanderson, and A. Montovani. 1989. Recombinant human interleukin 5 is a selective eosinophil attractant. Eur. J. Immunol. 19:701-708.
5. Yamaguchi, Y., T. Suda, S. Oha, K. Tominaga, Y. Miura, and T. Kasahara, 1991. Analysis of the survival of mature eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542-2547.
6. Kita, H., D. Weiler, R. Abu-Ghazalch, C. J. Sanderson, and G. J. Gleich. 1992. Release of granule proteins from eosinophils cultured with IL-5. J. Immunol. 149:629-635.
7. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501-506.
8. Coffman, R. L., B. W. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308-310.
9. Nagai, H., S. Yamaguchi, N. Inagak, N. Tsuruoka, Y. Hitoshi, and K. Takatsu. 1993. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci. 53:243-247.
10. Mauser, P. J., A. M. Pitman, X. Fernandez, S. K. Foran, G. K. Adams, III, W. Kreutner, R. W. Egan, and R. W. Chapman. 1995. Effects of antibody to IL-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467-472.
11. Kung, T. T., D. M. Stelts, J. A. Zurcher, G. K. Adams, III, R. W. Egan, W. Kreutner, A. S. Watnick, H. Jones, and R. W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell Mol. Biol. 13:360-365.
12. Gulbenkian, A. R., R. W. Egan, X. Fernandez, H. Jones, W. Kreutner, T. T. Kung, F. Payvandi, L. Sullivan, J. A. Zurcher, and A. S. Watnick. 1992. Interleukin-5 modulates eosinophil accumulation in allergic guinea pigs. Am. Rev. Respir. Dis. 146:263-265.
13. Plaut, M., J. H. Pierce, C. J. Watson, H. J. Hanley, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to crosslinkage of Fc epsilon RI or calcium ionophores. Nature 339:64-67.
14. Robinson, D., Q. Hamid, A. Bentley, S. Ying, A. B. Kay, and S. R. Durham. 1993. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
15. Garlisi, C. G., A. Falcone, T. T. Kung, D. Stelts, K. J. Pennline, A. J. Beavis, S. R. Smith, R. W. Egan, and S. P. Umland. 1995. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin. Immunol. Immunopathol. 75:75-83.
16. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone: III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
17. Mosmann, T. R., and R. L. Coffman. 1989. Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
18. Linsley, P. S., and J. A. Ledbetter. 1993. The role of CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
19. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339-343.
20. Roncarolo, M. G., H. Yssel, J.-L. Touraine, R. Baccheta, L. Gebuhrer, J. E. De Vries, and H. Spits. 1988. Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J. Exp. Med. 168:2139-2152.
21. Yssel, H., J. E. De Vries, M. Koken, W. Van Blitterswijk, and H. Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72:219-227.
22. Harrold, S., C. Genovese, B. Kobrin, S. L. Morrison, and C. Milcarek. 1991. A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Anal. Biochem. 198:19-29.
23. Srvastava, K. K., E. E. Cable, and H. L. Bonkovsky. 1993. Purifying nascent mRNA from nuclear run-on assays using guanidinium isothiocyanate. Biotechniques 15:226-227.
24. Romagnani, S. 1995. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15:121-129.
25. + T-helper cells after activation in vitro. Immunology 76:103-109.
26. King, C. L., R. J. Stupi, N. Craighead, C. H. June, and G. Thyphronitis. 1995. CD28 activation promotes Th2 subset differentiation by human CD4+ T cells. Eur. J. Immunol. 25:587-595.
27. Demeure, C. E., C. Y. Wu, U. Shu, P. V. Schneider, C. Heusser, H. Yssel, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J. Immunol. 152:4775-4782.
28. Umlauf, S., B. Beverly, O. Lantz, and R. H. Schwartz. 1995. Regulation of interleukin-2 gene expression by CD28 costimulation in mouse T-cell clones: both nuclear and cytoplasmic RNAs are regulated with complex kinetics. Mol. Cell. Biol. 15:3197-3205.
29. Flanagan, W. M., B. Corthesy, R. J. Bram, and G. R. Crabtree. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803-807.
30. Rolfe, F. G., J. E. Valentine, and W. A. Sewell. 1997. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription. Am. J. Respir. Cell Mol. Biol. 17:243-250.
31. Mori, A., M. Suko, O. Kaminuma, Y. Nishizaka, T. Mikami, T. Ohmura, A. Hoshino, S. Inoue, N. Tsuruoka, Y. Okumura, G. Sato, K. Ito, and H. Okudaira. 1996. A critical role of IL-2 for the production and gene transcription of IL-5 in allergen-specific human T cell clones. Int. Immunol. 8:1889-1895.
32. Sachs, A. B. 1993. Messenger RNA degradation in eukaryotes. Cell 74:413-421.
33. Zubiaga, A. M., E. Munoz, and B. T. Huber. 1991. Superinduction of IL-2 gene transcription in the presence of cyclohexamide. J. Immunol. 146:3857-3863.
34. Brorson, K. A., B. Beverly, S.-M. Kang, M. Lenardo, and R. H. Schwartz. 1991. Transcriptional regulation of cytokine genes in nontransformed T cells: apparent constitutive signals in run-on assays can be caused by repeat sequences. J. Immunol. 147:3601-3609.
35. Schandene, L., C. Alonso-Vega, F. Willems, C. Gerard, A. Delvaux, T. Velu, R. Devos, M. de Boer, and M. Goldman. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152:4368-4374.
36. Shaw, J., K. Meerovitch, R. C. Bleackley, and V. Paetkau. 1988. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J. Immunol. 140:2243-2248.
37. Bill, O., C. G. Garlisi, D. S. Grove, G. E. Holt, and A. M. Mastro. 1994. IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes. Cytokines 6:102-110.
38. Dokter, W. H. A., M. T. Esselink, S. J. Sierdsema, M. R. Halie, and E. Vellenga. 1993. Transcriptional and posttranscriptional regulation of the interleukin-4 and interleukin-3 genes in human T cells. Blood 81:35-40.
39. Naora, H., and I. G. Young. 1994. Mechanisms regulating the mRNA levels of interleukin 5 and two other coordinately expressed lymphokines in the murine T lymphoma EL4.23. Blood 83:3620-3628.
40. Hargrove, J. L., and F. H. Schmidt. 1989. The role of mRNA and protein stability in gene expression. FASEB J. 3:2360-2370.
41. Dubey, C., M. Croft, and S. L. Swain. 1996. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157:3280-3289.
42. June, C. H., J. A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211-216.
43. Shaw, J., K. Meerovitch, J. F. Elliot, R. C. Bleackley, and V. Paetkau. 1987. Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes. Mol. Immunol. 24:409-419.
44. Rajagopalan, L. E., and J. S. Malter. 1994. Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor. J. Biol. Chem. 269:23882-23888.
45. Bohanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) binds selectively to AU-UUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11:3288-3295.
46. Naora, H., and I. G. Young. 1995. Comparison of the mechanisms regulating IL-5, IL-4, and three other lymphokine genes in the Th2 clone D10.G4.1. Exp. Hematol. 23:597-602.